Non-peptide scaffolds for development of novel inhibitors of immunoproteasome - 2038
- Technology Benefits
- This invention targets immunoproteasomesubunit 35i for inhibition and has greater stability and efficacy than otherknown inhibitors. With greater stability and efficacy, this could potentiallyserve as an important therapeutic in cancer.
- Detailed Technology Description
- None
- *Abstract
-
None
- Country/Region
- USA
For more information, please click Here

